{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T18:36:29Z","timestamp":1648751789321},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.radonc.2009.03.001","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T19:36:24Z","timestamp":1238441784000},"page":"142-143","source":"Crossref","is-referenced-by-count":7,"title":["Epidermal growth factor receptor-inhibitors and radiotherapy-induced cutaneous adverse effects: \u201cKoebner-Phenomenon\u201d or radio-dermatitis?"],"prefix":"10.1016","volume":"92","author":[{"given":"Marco C.","family":"Merlano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvio G.","family":"Russi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2009.03.001_bib1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.radonc.2008.10.014","article-title":"Late onset of skin toxicity induced by EGFr-inhibitors","volume":"90","author":"Eriksen","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2009.03.001_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2008.09.007","article-title":"High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC Institutes","volume":"90","author":"Giro","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2009.03.001_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2008.09.018","article-title":"Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer","volume":"90","author":"Pryor","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2009.03.001_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2009.03.001_bib5","unstructured":"Merlano MC, Benasso M, Numico G. et al. Chemo-radiation (ctrt) and cetuximab (cmab) in locally advanced head and neck cancer (LA HNC). 33\u00b0 ESMO meeting, Stockholm 2008. Ann Oncol 2008;19(Suppl. 8) [abstr. 694PD]."},{"key":"10.1016\/j.radonc.2009.03.001_bib6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ijrobp.2007.05.063","article-title":"Ultrathin hydrocolloid dressing in skin damaged from alternating radiotherapy and chemotherapy plus cetuximab in advanced head and neck cancer (G.O.N.O. altercc Italian trial)","volume":"69","author":"Russi","year":"2007","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"10.1016\/j.radonc.2009.03.001_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.radonc.2007.04.034","article-title":"Acneiform rash secondary to cetuximab plus head and neck radiotherapy","volume":"85","author":"Mydin","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2009.03.001_bib8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMc071075","article-title":"Severe cutaneous reaction during radiation therapy with concurrent cetuximab","volume":"357","author":"Budach","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2009.03.001_bib9","unstructured":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE); 2006. p. 15. Available from: <http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf\/ [last visited December 20, 2008]."},{"key":"10.1016\/j.radonc.2009.03.001_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00066-008-1829-z","article-title":"Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab","volume":"184","author":"B\u00f6lke","year":"2008","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2009.03.001_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2307\/3578641","article-title":"Increased expression of the epidermal growth factor receptor in human epidermal keratinocytes after exposure to ionizing radiation","volume":"136","author":"Peter","year":"1993","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2009.03.001_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1523-1747.2003.12359.x","article-title":"Barrier function of the skin: \u2019\u2019La Raison d\u2019EOEtre\u2019\u2019 of the epidermis: a review","volume":"121","author":"Madison","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.radonc.2009.03.001_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/1535-7163.MCT-04-0238","article-title":"Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment","volume":"4","author":"Woodworth","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.radonc.2009.03.001_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9440(10)63654-1","article-title":"Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation","volume":"163","author":"Mascia","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.radonc.2009.03.001_bib15","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.4049\/jimmunol.174.8.5047","article-title":"ERK1\/2 regulates epidermal chemokine expression and skin inflammation","volume":"174","author":"Pastore","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.radonc.2009.03.001_bib16","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1200\/JCO.2007.16.0077","article-title":"The Koebner-phenomenon in epidermal growth factor receptor inhibitor-induced cutaneous adverse effects","author":"Gerber","year":"2008","journal-title":"JCO"},{"key":"10.1016\/j.radonc.2009.03.001_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1473-2165.2002.00406.x","article-title":"The Koebner phenomenon: review of the literature","volume":"16","author":"Weiss","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814009000954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814009000954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T20:28:22Z","timestamp":1545337702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814009000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0167814009000954"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2009.03.001","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}